Sponsor pipeline

Maria Sklodowska-Curie National Research Institute of Oncology clinical trial pipeline

Get alerts when Maria Sklodowska-Curie National Research Institute of Oncology's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 1 stopped, 0 with notable changes, 0 with minor changes only.

  1. Stopped

    Trial terminated

    Sponsor's reason: Following the recommendation of the Data Monitoring Committee (DMC), based on the results of the interim analysis, the Sponsor has decided to terminate the study prematurely

    Also in this update: Final enrollment: 49 participants (planned 124); Primary completion date changed from estimate of Dec 31, 2025 to Apr 21, 2026

    Maria Sklodowska-Curie National Research Institute of OncologyPhase 2 NCT04920968 Registry history

    Updated

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 2
9
Phase 3
1
Not charted: 4 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05271162 Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing… Cardiotoxicity Active, Not Recruiting 2026-06-16
Phase 2
NCT04875611 Nivolumab in Nasopharyngeal Cancer With Progression During or After Platinum-based… Nasopharyngeal Cancer Recruiting 2025-04-24
NCT05563467 Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma. Adrenocortical Carcinoma Recruiting 2025-04-02
NCT06201078 Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After Radiotherapy Local Recurrence of Malignant Tumor of Prostate Recruiting 2025-03-13
NCT06821906 Stereotactic Radiosurgery in the Treatment of Essential Tremor Essential Tremor Recruiting 2025-02-12
NCT06449781 177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk… Prostate Cancer Recruiting 2025-02-10
NCT06472583 Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the… Breast Cancer Recruiting 2024-06-25
NCT06128863 Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant… Neoadjuvant Active, Not Recruiting 2025-12-08
NCT06976021 Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or… Triple Negative Breast Cancer Not Yet Recruiting 2025-05-16
NCT04861207 Total Body Irradiation and Cladribine Before Allogeneic Hematopoietic Cell… Acute Myeloid Leukemia Myelodysplastic Syndromes Active, Not Recruiting 2025-04-24
Not applicable
NCT07546240 Optimal Radiotherapy - Heel Spur Syndrome - Randomized Clinical Trial Heel Spur Syndrome Recruiting 2026-04-22
NCT07216157 NoSeal Trial: Comparing Sealants Versus No Sealant for Preventing CSF Leak After… CerebroSpinal Fluid (CSF) Leak Recruiting 2025-10-14
NCT06472570 Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours Head and Neck Cancer Recruiting 2024-06-25
Not specified
NCT06928974 Functional Abdominal Wall Reconstruction Prune Belly Syndrome Active, Not Recruiting 2025-04-15

Disease areas by active trials, top 10 of 13

Breast Cancer (2) · Head & Neck Cancer (2) · Acute Myeloid Leukemia (AML) (1) · Cervical Cancer (1) · Endometrial Cancer (1) · Heart Disease (1) · Kidney Cancer (1) · Leukemia (1) · Melanoma (1) · Myelodysplastic Syndromes (MDS) (1)

Get alerts when Maria Sklodowska-Curie National Research Institute of Oncology's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free